{"filings":[{"id":696676,"accession_number":"0001493152-26-025433","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2026-05-27T20:35:28+00:00","items":["1.01","2.03","3.01","3.02","9.01"],"status":"ready","headline":"DNA X receives Nasdaq delisting notice; issues $3.05M convertible note to insider","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq delisting notice due to stockholders' deficit of $983,000 as of March 31, 2026; hearing requested.","Issued $3,052,788 convertible note to DNA Holdings Venture, Inc. at 10% interest, maturing Dec 31, 2026.","Note convertible into common at $6.00/share, subject to stockholder approval; proceeds for working capital.","Concurrently terminated a 'Put Option' under a prior Membership Interest Purchase Agreement.","Unregistered sale under Section 4(a)(2) and Rule 506(b); Purchaser is an accredited investor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":"2026-05-27","daily_digest_url":"/daily/2026-05-27","daily_digest_rank":1},{"id":556117,"accession_number":"0001493152-26-024639","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2026-05-20T20:50:16+00:00","items":["2.02","9.01"],"status":"ready","headline":"DNA X Q1 2026: asset sale nets $6.3M; no continuing revenue; raises $1.8M debt","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Completed sale of mobile device assets to NEXA for $15M (net $13.5M after working capital adj); $12M paid, $1.5M due Oct 2026.","Net income of $6.3M from asset sale (taxes, fees, severance); no revenue from continuing operations.","G&A expenses from continuing ops $3.6M, including $1.5M severance and $0.9M audit/tax costs.","Cash from continuing ops $1.2M at quarter end; entered agreement for $1.8M new debt on May 20, 2026.","Rebranded from Sonim Technologies to DNA X, Inc.; focuses on AI/crypto trading platform."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91700,"accession_number":"0001493152-26-020414","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"DNA X (SONM) dismisses auditor Baker Tilly, engages TAAD; 2025 audit includes going concern","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Audit committee dismissed Baker Tilly on April 27, 2026; engaged TAAD LLP for fiscal 2026.","Baker Tilly's 2025 report included substantial doubt about going concern.","Unremediated material weakness: insufficient staff with technical accounting expertise for complex transactions.","No disagreements with Baker Tilly on accounting principles or practices during prior periods."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91699,"accession_number":"0001493152-26-016655","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2026-04-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DNA X reports FY2025 no revenue from continuing ops; closes mobile asset sale for $15M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["No revenue from continuing operations in Q4 2025; G&A expenses $1.2M primarily for acquisition and sale costs.","Completed sale of mobile device assets to NEXA Mobility on Jan 23, 2026 for $15M; $13.5M paid immediately.","CEO and board member resigned Jan 30, 2026; Executive Chairman Mike Mulica named acting CEO; Scott Walker appointed to board.","Cash from continuing ops $1.3M at Dec 31, 2025; proceeds used to repay debt and support DNA X crypto platform.","Rebranded as DNA X, Inc. from Sonim Technologies; Nasdaq ticker remains SONM."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101953,"accession_number":"0001493152-26-008444","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K/A","filed_at":"2026-03-02T23:59:59+00:00","items":["2.01","9.01"],"status":"ready","headline":"DNA X amends 8-K to de-classify its share-based acquisition as not significant","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company determined that its acquisition of DNA X LLC for 223,201 shares (19.99% stake) is not a 'significant amount of assets' under SEC rules.","As a result, financial statements and pro forma information required by Item 9.01 will not be provided for the transaction.","Transaction was originally reported in December 2025; this amendment filed on March 2, 2026.","No other changes from the original report; prior disclosure of the deal itself remains unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101956,"accession_number":"0001493152-26-005966","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2026-02-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"DNA X appoints Mike Mulica as acting CEO; salary $450k, 50k RSUs; CFO Crolius gets 35k RSUs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mike Mulica appointed acting CEO effective Feb 9, 2026; base salary raised to $450,000 retroactive to Jan 30.","Mulica receives 50,000 RSUs vesting monthly over one year; COBRA reimbursement up to 12 months post-termination.","CFO Clay Crolius amendment acknowledges Jan 23 asset sale as a triggering event for change in control.","Crolius granted 35,000 RSUs vesting monthly over one year; COBRA reimbursement up to 6 months post-termination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101955,"accession_number":"0001493152-26-005202","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CEO Peter Liu and CCO Charles Becher resign; Scott Walker appointed to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Peter Liu resigned Jan 30, 2026, with $855,000 severance in two tranches ($427,500 each).","CCO Charles Becher resigned effective Jan 29, 2026, with $250,000 lump-sum severance.","Board appointed Scott Walker, co-founder of DNA Holdings, as director effective Jan 30.","All outstanding unvested stock options for Liu and Becher were accelerated and fully vested on separation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101954,"accession_number":"0001493152-26-003824","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2026-01-27T23:59:59+00:00","items":["1.01","1.02","2.01","5.03","7.01","8.01","9.01"],"status":"ready","headline":"Sonim Technologies completes asset sale to NEXA, rebrands as DNA X, Inc., pivots to digital asset management","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Asset sale of enterprise 5G solutions business to Pace Car Acquisition LLC (NEXA) closed Jan 23, 2026; post-closing cash ~$6.2M.","Company changed name to DNA X, Inc.; expects Nasdaq ticker change to DNAX from SONM.","Prepaid $5.4M in promissory notes to Streeterville Capital at 110% of outstanding balance.","Company believes it regained compliance with Nasdaq $2.5M stockholders' equity requirement.","DNA X will operate digital asset trading platform acquired Dec 2025; focus on on-chain trading protocol."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118292,"accession_number":"0001493152-25-029706","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-12-31T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Sonim stockholders approve sale of Legacy Business to Pace Car Acquisition LLC","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Stockholders approved Asset Purchase Agreement to sell Legacy Business (enterprise 5G solutions, rugged handsets, smartphones) to Pace Car Acquisition LLC.","Vote: 761,808 for, 124,170 against, 431 abstained; quorum of 59.6% of outstanding shares represented.","Advisory compensation for named executive officers approved: 646,227 for, 237,271 against, 2,911 abstained.","Adjournment proposal became moot and was not presented at the special meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118291,"accession_number":"0001493152-25-028292","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-12-18T23:59:59+00:00","items":["1.01","2.01","2.03","3.02","3.03","8.01","9.01"],"status":"ready","headline":"Sonim issues $1.2M convertible note, acquires DNA X DeFi protocol for 19.99% stock","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued $1.2M convertible promissory note to DNA Holdings, 10% interest, due Dec 2026, convertible at $5.50/share.","Acquired 100% of DNA X LLC for 223,201 shares (19.99% of outstanding) – an on-chain DeFi trading protocol.","DNA Holdings receives board nomination rights (1 officer, 1 director) if it holds ≥5% of common stock.","Put option: if DNA X doesn't hit $600M volume or $1M/day revenue by June 2026, DNA Holdings can swap shares back for DNA X.","Exchanged $629,640 of Streeterville note for 148,500 shares at $4.24; remaining Streeterville note ~$2.3M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118290,"accession_number":"0001493152-25-026254","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-12-05T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Sonim Tech authorizes contingent cash bonus for CFO and substitute cash grant for Executive Chairman tied to asset sale","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CFO Clay Crolius gets contingent cash bonus equal to value of $100,000 face amount phantom RSUs vesting on asset purchase closing.","Executive Chairman Michael Mulica gets substitute cash grant in lieu of $50,000 RSU grant due to insufficient shares under equity plan.","Both awards are payable only upon asset purchase agreement closing or other vesting events; null if deal terminated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118289,"accession_number":"0001493152-25-025141","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-11-26T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Sonim amends asset purchase agreement, removes reverse merger, adds payment condition","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Removed all references to reverse merger (RTO) and related Form S-4 filing from the purchase agreement.","Added requirement: if Closing Purchase Price < $0 after adjustments, Sonim must pay accounts payable to make price positive.","Added German subsidiary Sonim Technologies Germany GmbH to acquired subsidiaries.","Original deal remains $15M cash purchase of enterprise 5G solutions assets, as previously disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118288,"accession_number":"0001493152-25-022286","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-11-13T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Sonim regains Nasdaq minimum bid price compliance; bid price above $1.00 since Oct 27","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq Staff confirmed closing bid price at $1.00+ from Oct 27 to Nov 11, 2025.","Regained compliance with Nasdaq Listing Rule 5550(a)(2); delisting matter closed.","No further extension or conditions; Sonim common stock remains listed on Nasdaq."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118287,"accession_number":"0001493152-25-020309","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-10-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sonim Q3 revenue $16.2M (+45% seq), net loss narrows to $4.8M; asset sale to NEXA for $15M on track for Q4 close","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $16.2M, up 45% sequentially from Q2; GAAP net loss $4.8M vs $7.5M in Q2.","Adjusted EBITDA negative $2.0M, improving from negative $3.2M in Q2.","Entered definitive agreement to sell substantially all assets to NEXA for $15M cash plus up to $5M earn-out; expected close late Q4 2025.","Reverse stock split 1-for-18 effected Oct 27, 2025 to regain Nasdaq compliance.","Cash $2.1M; received $4.8M net proceeds from equity offerings during Q3."],"consensus_eps_estimate":null,"consensus_eps_actual":-19.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":44125000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118286,"accession_number":"0001493152-25-019183","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-10-24T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"Sonim Technologies approves 1-for-18 reverse stock split effective October 27, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved reverse split at Oct 16 special meeting; board set ratio at 1-for-18.","Effective 12:01 a.m. ET Oct 27; every 18 shares combined into 1, no fractional shares (cash in lieu).","Trading symbol unchanged (SONM) on Nasdaq Capital Market; new CUSIP 83548F 408.","Forward-looking statements cite risks including Nasdaq compliance; no revenue or earnings impact."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118285,"accession_number":"0001493152-25-018637","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-10-20T23:59:59+00:00","items":["3.01","5.02","5.03","5.07","8.01","9.01"],"status":"ready","headline":"Sonim appoints Executive Chairman, approves 1-for-18 reverse split; Nasdaq extension to Dec 31","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Michael Mulica appointed Executive Chairman effective Oct 16, 2025; receives $300k salary, $250k annual RSU grant, and $500k RSU award tied to asset purchase with Social Mobile.","Stockholders approved reverse stock split at 1-for-18 ratio, effective Oct 27, 2025, to regain compliance with Nasdaq minimum bid price.","Stockholders also approved increase in authorized shares from 100M to 1B; did not approve 1M share increase in equity incentive plan.","Nasdaq granted extension until Dec 31, 2025 to regain compliance with stockholders' equity minimum of $2.5M; company submitted compliance plan.","Reverse Stock Split will not issue fractional shares; cash in lieu will be paid."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134742,"accession_number":"0001493152-25-015997","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Sonim enters up to $500M equity facility with Chardan Capital Markets","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sonim may sell up to $500M in common stock to Chardan over 36 months at VWAP minus 3.5% discount.","Exchange cap of 2,066,747 shares (19.99% outstanding) unless shareholder approval or price condition met.","Minimum 33% of proceeds must prepay $2.755M note to Streeterville Capital, LLC issued July 11, 2025.","No restrictions on future financings; Chardan prohibits short sales and hedging.","Company can terminate with 10 trading days notice; Chardan terminates on customary events."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134741,"accession_number":"0001641172-25-025693","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-08-27T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Sonim receives Nasdaq deficiency notice for low stockholders' equity of $1.334M","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Sonim on Aug 22, 2025 that stockholders' equity of $1.334M as of June 30, 2025 is below the $2.5M minimum for continued listing.","Sonim also fails alternative compliance criteria (market value of listed securities $35M or net income $0.5M in recent fiscal years).","Company has until Oct 6, 2025 to submit a compliance plan; if accepted, Nasdaq may grant up to 180 days to regain compliance.","No immediate effect on trading of SONM common stock; Sonim is evaluating actions to regain compliance.","No assurance that the plan will be accepted or that Sonim can regain compliance within the extension period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134740,"accession_number":"0001641172-25-024038","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-08-14T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Sonim receives Nasdaq deficiency notice for minimum bid price non-compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Sonim on Aug 13, 2025, that bid price closed below $1.00 for 30 consecutive business days.","Company has 180 calendar days (until Feb 9, 2026) to regain compliance via $1.00 close for 10 consecutive days.","Failure may allow a second 180-day period if other listing standards are met; possible reverse stock split considered.","The notice has no immediate effect on trading of SONM on Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134739,"accession_number":"0001641172-25-023214","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-08-12T23:59:59+00:00","items":["1.01","2.03","5.02","9.01"],"status":"ready","headline":"Sonim enters €3M factoring at 15% discount, cuts warrant exercise price to $0.75","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered factoring agreement with Tradewind GmbH; eligible receivables purchased at 15% discount; max financing €3M.","Interest on facility is greater of 4.0% or EURIBOR + 3.5%; late fee 0.18% at 95 days.","Amended subscription agreements to reduce warrant exercise price to $0.75 per share.","Compensation committee granted cash award to non-employee directors in lieu of RSUs due to insufficient shares under equity plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134738,"accession_number":"0001641172-25-022814","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sonim Q2 net loss $7.5M, revenue $11.2M; Social Mobile acquisition for $15M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net loss of $7.5M vs net income $0.5M in Q1; revenue $11.2M down 33% QoQ from $16.7M (incl. $5.3M one-time item).","Gross profit $0.8M (8% margin) vs $8.4M (50%) Q1; includes $1.1M impairment on contract fulfillment assets.","Adjusted EBITDA negative $3.2M, flat QoQ; cash $2.0M at quarter end, raised $7.1M post-quarter via stock and debt.","XP Pro smartphone launched with AT&T; H500 5G hotspot shipping to Europe for Deutsche Telekom, Telenor, Swisscom.","Asset sale to Social Mobile for $15M base + $5M earn-out; expected Q4 close; all five director nominees elected."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.91,"consensus_revenue_estimate":null,"consensus_revenue_actual":27911000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134737,"accession_number":"0001641172-25-020655","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-07-23T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"Sonim Technologies grants special cash awards to special committee and reports annual meeting results","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Compensation committee approved $55,000 special cash award to each special committee member and $35,000 to the chair.","Annual meeting had 64% quorum; stockholders elected James Cassano, Peter Liu, Mike Mulica, Jack Steenstra, and George Thangadurai as directors.","Amendment to 2019 equity plan increasing shares by 600,000 was not approved (1,611,140 for, 2,948,436 against).","Advisory say-on-pay vote was not approved (1,626,781 for, 2,970,900 against).","Advisory vote on frequency of future say-on-pay approved every 3 years (3,457,977 votes for 3 years)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134736,"accession_number":"0001641172-25-020576","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-07-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Sonim sells enterprise 5G solutions business for $15M cash plus up to $5M earn-out; plans reverse merger","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Purchase price $15M cash (subject to working capital adjustments) plus earn-out: 50% of net revenue above $70M in 12 months ending June 30, 2026, capped at $5M.","Company intends to pursue a reverse merger (RTO) with a target; RTO is complementary to and not a substitute for the asset sale.","Transaction requires stockholder approval; no financing condition; termination fee of $1M payable by company under certain conditions.","Sale includes substantially all assets of enterprise 5G business: rugged handsets, smartphones, wireless internet devices, software, services, and accessories."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134735,"accession_number":"0001641172-25-020061","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Sonim issues $2.755M secured note to Streeterville Capital; net proceeds $2.5M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Note carries 9% annual interest, matures 18 months from July 11, 2025; OID of $225K and $30K transaction fees.","Prepayment: optional at 110% of principal; mandatory prepayment of 33% of any future financing proceeds capped at outstanding balance.","Note secured by first-priority lien on all assets including intellectual property; restrictive covenants on debt and equity issuances.","As of July 11, 2025, Sonim had 17,738,905 shares of common stock outstanding.","Placement agent Ascendiant Capital Markets received $150K fee (6% of gross proceeds)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134734,"accession_number":"0001641172-25-017611","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-07-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Sonim Technologies prices public offering of 7.4M shares at $0.75, raising ~$4.9M net","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 7,400,000 common shares at $0.75 per share closed July 2, 2025.","Net proceeds estimated at $4.9 million after placement agent fees and expenses.","Placement agent Roth Capital Partners receives 7% cash fee and warrants for 208,875 shares.","Proceeds to be used for working capital, general corporate purposes, and potential debt repayment.","Registration statement (S-1) was declared effective by SEC on June 30, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151645,"accession_number":"0001641172-25-016375","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-06-25T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Sonim Technologies signs LOI for reverse takeover with AI HPC factory valued at ~$300M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Target is private US company building Nvidia-based HPC AI factories; valuation ~$300M supported by fairness opinion.","Sonim stockholders to retain $17.5M in combined company equity; Target's stockholders would own majority.","Combined company expected to adopt new corporate name and ticker symbol while maintaining Nasdaq listing.","Transaction subject to closing of Sonim's operating asset sale for $15M plus $5M earnout, plus stockholder and regulatory approvals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151644,"accession_number":"0001641172-25-013815","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Sonim Technologies replaces auditor Moss Adams with Baker Tilly after merger","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Moss Adams merged into Baker Tilly US, LLP effective June 3, 2025; Baker Tilly appointed as new auditor.","No disagreements or reportable events occurred between Sonim and Moss Adams during 2023-2025 interim.","Prior audit reports on financials for years ended Dec 31, 2024 and 2023 were unqualified.","Material weaknesses in internal controls were previously disclosed in 2022 and 2023 filings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151643,"accession_number":"0001641172-25-011178","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-05-16T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Sonim Technologies raises $1.375M via private placement of stock and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["1.1M shares of common stock and warrants for 550K shares sold for $1.375M total.","Warrants exercisable at $1.3864/share, expire May 12, 2030, subject to beneficial ownership limits.","Finder's fee of $110,000 incurred; net proceeds for working capital and general corporate purposes.","Company agreed to file registration statement by July 12, 2025 to register resale of the securities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151642,"accession_number":"0001641172-25-009689","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sonim Q1 revenue $16.7M (+12% seq), GAAP net income $0.5M; adj EBITDA -$3.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $16.7M, +12% sequentially; GAAP net income $0.5M vs Q4 2024 loss of $21.6M.","Adjusted EBITDA -$3.2M, improved from -$16.6M in Q4; cash $2.1M.","Raised $6.5M via ATM and debt for expansion and European growth.","XP Pro Thermal 5G orders, Verizon Frontline status, T-Mobile XP3plus launch targeting first responders.","Set to launch five products in Q2 with Tier 1 carriers and distribution partners."],"consensus_eps_estimate":null,"consensus_eps_actual":0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":16721000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151641,"accession_number":"0001641172-25-005546","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-04-21T23:59:59+00:00","items":["1.01","3.03","5.02","5.03","9.01"],"status":"ready","headline":"Sonim adopts poison pill in response to Orbic's $4.00/share takeover proposal; accelerates executive RSU vesting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Adopted limited-duration stockholder rights agreement triggered at 15.5% ownership (20% for passive investors), expiring April 21, 2026.","Response to unsolicited Orbic North America proposal to buy outstanding shares for $4.00 per share and Orbic's rapid accumulation.","Accelerated vesting of all previously granted RSUs for 81 employees effective April 17, 2025, including CEO Peter Liu (63,604 RSUs), CFO Clay Crolius (33,922), and CCO Charles Becher (70,671).","Rights include flip-in, flip-over, and exchange provisions; redeemable at $0.001 per right before an acquiring person emerges.","Board created Series A Junior Participating Preferred Stock with economic terms similar to 1,000 shares of common per preferred share."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151640,"accession_number":"0001641172-25-004972","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-04-16T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Sonim amends CFO employment agreement, enhancing severance upon change in control","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Change in Control definition expanded to include removal of majority of Board over two years or asset sale/liquidation.","Severance protection period extended to 12 months after a Change in Control.","Added Qualified Termination Event covers termination without cause or constructive termination by CFO.","Severance now includes guaranteed pro-rated bonus of at least 20% of base salary.","Enhanced severance conditional on release and compliance with non-solicitation obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151639,"accession_number":"0001641172-25-002512","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-04-03T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Sonim amends CEO severance to 150% salary plus bonus; expands special committee","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Peter Liu's employment agreement amended: severance on Change in Control increased to 150% of base salary plus pro-rated target bonus.","Change in Control definition expanded to include removal of majority of Board within 2 years or sale of substantially all assets.","Severance protection period extended to 12 months post-Change in Control; Good Reason triggers added (e.g., material diminution in position/pay).","Special Committee of Board adds third independent director, Jack Steenstra, to evaluate potential strategic transactions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170491,"accession_number":"0001641172-25-001695","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-03-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sonim Technologies reports FY2024: Q4 revenue $15M (+12%), full year $58.3M (-38%)","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $15.0M (+12% YoY); full year revenue $58.3M (-38% YoY) due to strategic shift from white-label to own products.","Q4 gross margin negative 1%; full year 17%; $3.0M impairment on contract fulfillment assets reduced gross margin by 20pp in Q4.","Cash $5.3M at year-end; post-year-end raised $3.7M from ATM and $3.0M from new debt.","New product launches include H500 5G hotspot, XP Pro ultra rugged smartphone; secured carrier agreements with Verizon, Telstra, etc.","2025 outlook optimistic for revenue growth and profitability as new products scale globally."],"consensus_eps_estimate":null,"consensus_eps_actual":0.08,"consensus_revenue_estimate":null,"consensus_revenue_actual":16721000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170490,"accession_number":"0001493152-25-007911","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-02-21T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"Sonim issues $3.3M promissory note to Streeterville Capital, net proceeds $3M","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Note principal $3.3M; $270K OID and $30K transaction costs deducted; net proceeds $3M.","Interest 9% per annum; maturity 18 months; 110% prepayment penalty on partial prepayments.","Lender may redeem up to $330K/month starting 6 months; company can defer with 1% fee.","Covenants restrict other debt/convertible issuances without lender consent; includes MFN clause.","Ascendiant Capital received $180K (6% of gross) as placement agent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170489,"accession_number":"0001493152-25-005904","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-02-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Sonim awards RSUs to 97 employees; CEO Liu receives 63,604 units","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Peter Liu awarded 63,604 RSUs; CCO Charles Becher 70,671; CFO Clay Crolius 33,922.","Each award vests in two equal installments at 90 and 180 days from Feb 6, 2025 grant date.","Grants issued under Sonim 2019 Equity Incentive Plan, contingent on continued employment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170488,"accession_number":"0001493152-25-003315","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-01-23T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Sonim Technologies forms special committee to evaluate strategic alternatives after AJP Holding 13D/A","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special Committee comprised of Mike Mulica (chair) and James Cassano, both independent directors.","Roth Capital Partners engaged as financial advisor to evaluate options including sale or merger.","Orbic North America LLC identified as one of multiple parties expressing strategic interest.","Press release confirms inbound interest following January 17, 2025 Schedule 13D/A filing by AJP Holding Company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170487,"accession_number":"0001493152-25-002477","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2025-01-16T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sonim Q4 preliminary: $15.2M revenue (+13% YoY), net loss $20-24M (vs $3M Q3), cash $5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue ~$15.2M, up 13% YoY from $13.4M and up sequentially from $15.0M in Q3.","GAAP net loss expected $20-24M, compared to $3M in Q3, driven by $12M R&D for new product launches.","Also: $4M COGS adjustment, $2M credit loss provision, $1M restructuring charge.","Cash expected ~$5M at year-end; launched new 5G hotspots and smartphones with Verizon, Telstra, Bell Canada.","Expanded global distribution to Europe, Africa, Australia; new manufacturing in Taiwan (TAA certified) and Vietnam."],"consensus_eps_estimate":null,"consensus_eps_actual":-7.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":58298000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187475,"accession_number":"0001493152-24-045138","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2024-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sonim Q3 revenue up 30.4% sequentially to $15.0M; net loss narrows to $2.5M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $15.0M, up 30.4% from Q2 2024; GAAP net loss $2.5M vs. $6.6M in Q2 including $3.2M impairment.","Adjusted EBITDA negative $1.1M, improved from negative $2.0M in prior quarter. Cash $9.1M.","Launched H700 5G rugged mobile hotspot in Australia and H500 5G hotspot with Verizon Wireless in North America.","Secured major device upgrade agreement with a leading Fortune 500 food and beverage company.","Unveiled XP400 smartphone and XP100 feature phone for European and South African markets."],"consensus_eps_estimate":-12.1176,"consensus_eps_actual":-2.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":43314000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl+finnhub","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203990,"accession_number":"0001493152-24-038533","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2024-09-27T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Sonim enters $2.5M receivables factoring facility with LS DE LLC","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Agreement provides advances of 80% of invoice face value up to $2.5M total.","Fees: invoice purchase fee of 0.20% per invoice plus daily usage fee of 0.0388%.","Initial term of 12 months, auto-renewing; secured by all accounts receivable and inventory.","Default interest rate is lesser of 24% per annum or maximum allowed by law.","Facility includes standard covenants limiting additional debt, liens, and dividends."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203989,"accession_number":"0001493152-24-030962","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2024-08-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Sonim Q2 revenue $11.5M, net loss $6.6M; expects H2 sequential growth","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenues of $11.5M, down from $16.8M in Q1 2024.","GAAP net loss of $6.6M included a $3.2M impairment charge; adjusted EBITDA was -$2.0M.","Ended quarter with $9.6M cash; raised $3.85M in an above-market equity transaction.","Began product launches with tier-one carriers; expects sequential revenue growth in Q3 and Q4.","Secured new product awards, including a 5G variant of the XP3plus flip phone with a US tier-one carrier."],"consensus_eps_estimate":-9.9144,"consensus_eps_actual":-2.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":28292000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203988,"accession_number":"0001493152-24-030465","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Sonim Technologies enters ATM equity offering agreement for up to $8.94M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company entered Sales Agreement with Roth Capital Partners for ATM offering of common stock up to $8,943,000.","Shares sold at prevailing market prices; Agent receives 3.0% commission on gross proceeds.","Company not obligated to sell any shares; no assurance of any sales under the agreement.","Securities issued under effective shelf registration statement (File No. 333-278577).","Agreement includes indemnification; may be terminated by either party upon prior notice."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203987,"accession_number":"0001493152-24-030182","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Sonim Technologies regains Nasdaq minimum bid price compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Sonim on August 2, 2024, that its closing bid price was $1.00 or greater from July 18 to August 1, 2024.","Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and the matter is closed.","The notification resolves previous deficiency regarding minimum bid price requirement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203986,"accession_number":"0001493152-24-028272","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2024-07-18T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"Sonim Technologies completes 1-for-10 reverse stock split effective July 17, 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split ratio 1-for-10 approved by board after stockholder authorization at June 20, 2024 annual meeting.","Certificate of amendment filed with Delaware; effective 5:00 p.m. ET on July 17, 2024.","Every ten shares combined into one; no fractional shares, one full share issued for any fractional.","Common stock to trade split-adjusted under symbol SONM from July 18, 2024; new CUSIP 83548F309.","Stockholders authorized split at ratio range 1:2 to 1:15; board set final ratio at 1:10."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203985,"accession_number":"0001493152-24-027938","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2024-07-16T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Sonim Technologies announces 1-for-10 reverse stock split to regain Nasdaq compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved 1-for-10 reverse stock split; effective 5:00 p.m. ET on July 17, 2024.","Common stock (SONM) to commence trading on split-adjusted basis July 18, 2024; new CUSIP 83548F 309.","No fractional shares; one full share issued in lieu of any fractional share.","Split aims to increase share price to regain compliance with Nasdaq minimum bid price requirement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220657,"accession_number":"0001493152-24-024726","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2024-06-21T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Sonim shareholders approve reverse stock split, authorized share increase, and equity plan expansion","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Approved reverse stock split at ratio of 1-for-2 to 1-for-15, at Board discretion, within one year.","Approved increase in authorized common stock from 100M to 200M shares, at Board discretion within one year.","Approved amendment to 2019 Equity Incentive Plan adding 3,000,000 shares for issuance.","Stockholders did NOT approve proposal to limit officer liability under Delaware law.","Re-elected five directors and ratified Moss Adams as independent auditor for FY2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220656,"accession_number":"0001493152-24-023873","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2024-06-14T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Sonim Technologies amends bylaws for meeting chair/secretary and technical corrections","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board gains power to designate chairperson and secretary for stockholder meetings.","Technical corrections and nonsubstantive edits to cross-references in Section 43 of bylaws.","Amendments approved and effective as of June 14, 2024.","No change to fiscal year; no material impact on shareholder rights."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220655,"accession_number":"0001493152-24-022549","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K","filed_at":"2024-06-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Sonim Technologies extends registration statement filing deadline to September 20, 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Company amended Registration Rights Agreement with investor Jiang Liu on June 2, 2024.","Filing deadline for initial registration statement pushed to September 20, 2024.","No other changes to agreement terms; extension granted by investor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220651,"accession_number":"0001493152-24-022411","cik":1178697,"company_name":"DNA X, Inc.","ticker":"SONM","form_type":"8-K/A","filed_at":"2024-06-03T23:59:59+00:00","items":["5.08"],"status":"ready","headline":"Sonim Technologies sets 2024 annual meeting for June 20; advances proposal deadlines","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Annual meeting date changed to June 20, 2024, advanced >30 days from Sept 28, 2023 meeting.","Rule 14a-8 stockholder proposal deadline was May 13, 2024 (already passed).","Deadline for director nominations and other business under Bylaws is June 13, 2024.","Stockholder proposals must comply with Exchange Act Rules and Delaware law."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":5953072.235872235,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}